The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of olaparib combined to metronomic cyclophosphamide and metformin in patients with recurrent advanced/metastatic endometrial by molecular subtypes: ENDOLA phase I/II trial.
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; Eisai; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); NOVARTIS (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech; SEAGEN
 
Alexandra Leary
Honoraria - Gerson Lehrman Group; Medscape; peervoice
Consulting or Advisory Role - Apmonia Therapeutics (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD (Inst); PEGASCY; Seagen (Inst); Tesaro (Inst); zentalis (Inst)
Research Funding - Adaptimmune (Inst); AstraZeneca (Inst); Inivata (Inst); MSD Oncology (Inst); OSE Immunotherapeutics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Philippe Follana
No Relationships to Disclose
 
Cyril Abdeddaim
Honoraria - GlaxoSmithKline; Merck
Consulting or Advisory Role - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline; GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Merck
 
Florence Joly
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; sanofi/3A; Seagen; Viatris
Travel, Accommodations, Expenses - AstraZeneca; BMS; Chugai Pharma; Eisai; Eisai; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology
 
Sylvie Bin
No Relationships to Disclose
 
Laurent Villeneuve
No Relationships to Disclose
 
Marine Alexandre
No Relationships to Disclose
 
Maxime Bonjour
No Relationships to Disclose
 
Vérane Schwiertz
No Relationships to Disclose
 
Anais Boulai
No Relationships to Disclose
 
Manuel Rodrigues
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Immunocore
Research Funding - Daiichi Sankyo/Astra Zeneca; Johnson & Johnson/Janssen (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Max Piffoux
No Relationships to Disclose
 
Gilles Freyer
Honoraria - Amgen; AstraZeneca; Biogaran Pharmaceuticals; bms; Gilead Sciences; GlaxoSmithKline; Menarini Group; Novartis; pfizer; seagen; seagen; veracyte
Consulting or Advisory Role - Lilly
Research Funding - AstraZeneca (Inst); bms (Inst); myln (Inst)
 
Celine Callens
No Relationships to Disclose